AU
SHC icon

AlphaGrep UK’s Sotera Health SHC Stock Holding History

AlphaGrep UK’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,653
Closed -$282K – 929
2026
Q1 		$282K Buy
+19,653
New +$326K 0.08% 544

Other funds holding SHC

DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

AlphaGrep UK's SHC Position: Q2 2026 in Review

AlphaGrep UK sold out of Sotera Health (SHC) in Q2 2026, closing a stake of 19,653 shares — an estimated $282K sold.

AlphaGrep UK first reported a position in SHC in Q1 2026 and held it in 1 quarter. The position peaked at $282K in Q1 2026. 298 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • AlphaGrep UK reported no remaining Sotera Health position as of Q2 2026 after selling out during the quarter.
  • AlphaGrep UK sold 19,653 Sotera Health shares in Q2 2026, an estimated $282K.
  • AlphaGrep UK first reported a position in Sotera Health in Q1 2026 and held it in 1 quarter.
  • AlphaGrep UK's Sotera Health position peaked at $282K in Q1 2026.
  • 298 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.